UNITED STATES MULTIPLEX ASSAY MARKET FORECAST 2024-2032

The United States multiplex assay market segmentation includes product and service, type, end-user, technology, and application. The application segment includes companion diagnostics, clinical diagnostics, and research and development.

Traditionally, diseases like gastrointestinal infection, cardiovascular diseases, cancer, and others have been diagnosed clinically using single-plex assays. However, multiplex assays offer advantages over conventional methods, requiring less sample volume and boasting higher throughput and improved infection detection capabilities. They are increasingly utilized for detecting multiple analytes in a single test, with applications in diagnosing cancer, autoimmune diseases, infectious diseases, etc.

Furthermore, multiplex assays can offer cost savings compared to single-plex assays by reducing the cost per data point through simultaneous testing of multiple analytes in a single reaction. Additionally, they save time by enabling simultaneous testing of multiple analytes, thus reducing the necessity for multiple separate tests.

Whereas companion diagnostics play a crucial role in ensuring the safe and efficient utilization of biological products or drugs. They aid physicians in determining the suitability of a therapeutic product for a patient and in assessing potential risks or side effects. This process facilitates the identification of the most appropriate therapy for each individual.

Furthermore, companion diagnostics track the patient’s response to treatment, enhancing both safety and efficacy. Multiplex assays are becoming increasingly prevalent in companion diagnostics. The current approach to companion diagnostic development, which relies on single protein or simple mutation assays, often falls short in capturing the intricate biology underlying disease or drug response.

Some of the key companies operating in the United States multiplex assay market are Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton, Dickinson and Company (BD), etc.

Agilent Technologies Inc. (Agilent) offers a comprehensive range of instruments, software, services, and consumables tailored to identify, analyze, and measure the biological and physical characteristics of substances and products. Its clientele includes clinical and routine diagnostics, as well as analytical laboratories, benefitting from a diverse technology platform suite. It caters to various sectors such as life science research, chemical and energy, environmental and forensics, diagnostics and clinical, and the food industry.

Further, Agilent promotes its offerings through multiple channels, including direct sales, resellers, e-commerce, distributors, and representatives. The company has manufacturing facilities and research and development (R&D) centers strategically located across Europe, Asia-Pacific, and North America. Agilent operates from its headquarters in Santa Clara, California, the United States.